Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Roberto Alejandro Diez"'
Autor:
Ricardo Enrique Barcia, Guillermo Alberto Keller, Natalia Bello, Francisco Azzato, Roberto Alejandro Diez, Guido Giunti
Publikováno v:
Prague Medical Report, Vol 124, Iss 4, Pp 392-412 (2023)
The COVID-19 pandemic generated a great impact on health systems. We compared evolution, polypharmacy, and potential drug-drug interactions (P-DDIs) in COVID-19 and non-COVID-19 hospitalizations during first wave of pandemic. Prescriptions for hospit
Externí odkaz:
https://doaj.org/article/13c05ec161b54b759167b43671907d5f
Autor:
Ricardo Enrique Barcia, Guillermo Alberto Keller, Francisco Azzato, Roberto Alejandro Diez, Mathias Sielecki, Ricardo Samson Kleine, Juan Alberto Lescano, Guido Giunti
Publikováno v:
Reviews on Recent Clinical Trials. 18:156-166
Objectives: We evaluated polypharmacy and possible drug-drug interactions (p-DDIs) in hospitalized patients before and after using the SIMDA Computerized Medical Decision Support System (CMDSS). Materials and Methods: We included the prescriptions of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d102b0f3a4509c7ec6a03f85887beeb4
https://doi.org/10.2174/1574887118666230208124744
https://doi.org/10.2174/1574887118666230208124744
Autor:
Giuliana Haddad Taralli de Mendonça, Karen Sacoman Barbosa, Sérgio Alberto Cunha Vencio, Stevin Zung, Cristiane Cremiude Ribeiro-Fernandes, Larissa Fontes-Generoso, Roberto Alejandro Diez, Antonio Carlos Amedeo Vattimo, Meirenice Oliveira da Silva, Douglas Costa Morais, Florencia Amato
Publikováno v:
Brazilian Journal of Health Review. 3:9444-9453
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5e34fc4339c75493a92983ffa5ae665e
https://doi.org/10.34119/bjhrv3n4-180
https://doi.org/10.34119/bjhrv3n4-180
Autor:
Guillermo Di Girolamo, Roberto Alejandro Diez, Patricia N. Quiroga, Guillermo Alberto Keller, Nicolás Fernández, Nancy Mónica Olivera, Cecilia Villa Etchegoyen
Publikováno v:
Journal of Opioid Management. 14:335-344
Objective: To evaluate frequency and risk factors for dextropropoxyphene-induced QT-interval prolongation in the clinical setting. Design: Prospective, noninterventional, observational, longitudinal cohort approach. Electrocardiograms were blindly ev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::350089e2ac4bd42c1352056d3913dc84
https://doi.org/10.5055/jom.2018.0466
https://doi.org/10.5055/jom.2018.0466
Autor:
M. Seijo, Roberto Alejandro Diez, Guillermo Alberto Keller, Silvina Rosana Mastaglia, Beatriz Oliveri, J. Somoza, G. Di Girolamo, G. Brito
Publikováno v:
European Journal of Clinical Nutrition. 69:697-702
BACKGROUND/OBJECTIVES: The superiority of cholecalciferol (D3) over ergocalciferol (D2) in sustaining serum 25-hydroxy vitamin D (25OHD) levels is controversial. To compare D2 with D3 we performed a single-blind, placebo-controlled randomized trial s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11df203d02307df6a8e95c3cb54b3cd8
https://doi.org/10.1038/ejcn.2015.16
https://doi.org/10.1038/ejcn.2015.16
Autor:
María Laura Ferreirós Gago, Roberto Alejandro Diez, Guillermo Alberto Keller, Guillermo Di Girolamo
Publikováno v:
Current Pharmaceutical Design. 23
Background: Differences in drug response among patients are common. Most major drugs are effective in only 25 to 60 percent of the patients, in part due to the CYP enzymes, whose activity vary up to 50-fold between individuals for some index metaboli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a296da3328b14c76ea44d0ece30fcfc
https://doi.org/10.2174/1381612823666170207100724
https://doi.org/10.2174/1381612823666170207100724
Autor:
Nancy Mónica Olivera, Roberto Alejandro Diez, Guillermo Alberto Keller, Nicolás Fernández, Di Girolamo G, Villa Etchegoyen Mc, Patricia N. Quiroga
Publikováno v:
International journal of clinical pharmacology and therapeutics. 55(3)
A prolongation of the QTc-interval has been described for several opioids, including pethidine (meperidine). OBJECTIVE To evaluate in the clinical setting the frequency and risk factors associated with the QT-interval prolongation induced by meperidi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06d0503188219c87c6b0acdf8fe474b7
https://pubmed.ncbi.nlm.nih.gov/27509828
https://pubmed.ncbi.nlm.nih.gov/27509828
Autor:
Mariana Papouchado, Julio Carfagnini, Marcelo Andrés Kauffman, Aída Sterin-Prync, Carlos Nagle, Alejandro Vidal, Monica M. Lahoz, Roberto Alejandro Diez
Publikováno v:
Journal of Medical Primatology. 38:187-191
Background Recombinant human interferon (hIFN beta) is indicated for the treatment of multiple sclerosis. Its effect presents species restriction, thus lacking biological activity on most mammals. Although there have been previous studies of the phar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69990edf70326804228bc3b945a40ca8
https://doi.org/10.1111/j.1600-0684.2008.00333.x
https://doi.org/10.1111/j.1600-0684.2008.00333.x
Autor:
O. A. Jacquez, M. E. Acevedo, A. S. Mistchenko, G. Di Girolamo, Roberto Alejandro Diez, Guillermo Alberto Keller
Publikováno v:
Drug Safety. 31:885-960
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a7d18f45f02999caa6bb27d06ebaabf2
https://doi.org/10.2165/00002018-200831100-00132
https://doi.org/10.2165/00002018-200831100-00132